green, page-19

I think you'll see a bevvy of interesting and proven biotech investors supporting this from the u/w issue by Forrest and KTM.

Both experienced in this space and both have kudos in attracting strong investors into the space. Share consolidation will also see a tighter base and move (Forrest has done this before).

I think you'll see better than 2.5 shortly and then could get a real re-rating soon after as smart investors soak the small supply.

Agree with MF - a large multibagger